ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy.
ILC Therapeutic’s platform approach has produced two first-in-class lead candidates, Alfacyte™ and Dermacyte™ focused on antiviral and dermatological indications respectively, which are progressing towards the clinic.
Company Details
- Employees
- 7
- Address
- Spaces, 100 West George Street,united Kingdom
- Phone
- +44 (0) 7403 554048
- co****@****ics.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ilctherapeutics.com
- HQ
- Glasgow
Ilc Therapeutics Questions
Ilc Therapeutics's helpline number is +44 (0) 7403 554048
Ilc Therapeutics's website is ilctherapeutics.com
Ilc Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/ilctherapeutics
Ilc Therapeutics has
7 employees.
View email and phone details for 7
employees at Ilc Therapeutics.
Ilc Therapeutics's industry is
Pharmaceutical Manufacturing
Ilc Therapeutics's top competitors are
Brenus Pharma,
Nanosyrinx,
Bdd,
Syantra Inc.,
Arsenal Biosciences, Inc.,
Phoremost Ltd,
Superluminal Medicines Inc.,
Bioascent,
Invizius,
Vaxcyte.
Ilc Therapeutics's support email address is contact@ilctherapeutics.com
Ilc Therapeutics's categories are Pharmaceutical Manufacturing
